
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutrali... Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.16 | -12.030075188 | 1.33 | 1.4525 | 1.16 | 303986 | 1.24958447 | CS |
4 | -0.57 | -32.7586206897 | 1.74 | 1.86 | 1.16 | 267812 | 1.44066325 | CS |
12 | -1.59 | -57.6086956522 | 2.76 | 2.81 | 1.16 | 509360 | 2.04530008 | CS |
26 | -2.91 | -71.3235294118 | 4.08 | 5.07 | 1.16 | 475110 | 3.05985072 | CS |
52 | -2.46 | -67.7685950413 | 3.63 | 6.35 | 1.16 | 392062 | 3.24856363 | CS |
156 | -6.83 | -85.375 | 8 | 37.55 | 1.16 | 361980 | 5.73602644 | CS |
260 | -6.83 | -85.375 | 8 | 37.55 | 1.16 | 361980 | 5.73602644 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions